SMAD4 rs377767325: Understanding This Rare Genetic Variant
The genetic variant rs377767325 is a rare alteration located within the SMAD4 gene. It has been identified in clinical research as a pathogenic variant associated with juvenile polyposis syndrome.
What each genotype means
Pathogenic variant carrier
This genotype involves a duplication of the TGTCTGT sequence in the SMAD4 gene. Research indicates this specific variant is classified as pathogenic and is associated with Juvenile polyposis syndrome; please consult with a medical geneticist or clinician to discuss these findings.
This is a rare genotype that is not typically found in the general population.
What is rs377767325 and Where is it Located?
The variant rs377767325 is a specific genetic change identified in the human genome. In scientific databases, it is categorized as an insertion/deletion variant, specifically involving the duplication of the sequence TGTCTGT. This variant is located on chromosome 18 within the SMAD4 gene. Because it occurs within a gene that provides instructions for making a protein, it is considered a coding variant rather than an intergenic one. Geneticists use the rsID (reference SNP cluster ID) rs377767325 to uniquely identify this specific location and change in the DNA sequence across different research studies and clinical databases.
The Role of the SMAD4 Gene
The SMAD4 gene plays a critical role in cell signaling. It encodes a protein that acts as a signal transducer, helping to transmit messages from the cell surface to the nucleus. This pathway is essential for regulating various cellular processes, including cell growth, maturation, and programmed cell death. By controlling these signals, the SMAD4 protein helps maintain the normal structure and function of tissues throughout the body, particularly in the gastrointestinal tract. When the SMAD4 gene is altered, the resulting protein may not function correctly, which can disrupt these vital signaling pathways and potentially lead to the development of abnormal tissue growths.
Clinical Associations and Evidence Strength
Research has linked the rs377767325 variant to juvenile polyposis syndrome, a condition characterized by the development of multiple polyps in the gastrointestinal tract. The evidence for this association is classified as pathogenic in clinical databases like ClinVar. This means that clinical and functional studies have provided strong evidence that this specific genetic change contributes to the development of the syndrome. It is important to note that while this variant is associated with a specific condition, genetic associations are complex. The presence of a variant does not guarantee that an individual will develop a specific health outcome, as other genetic and environmental factors often play a role in the expression of a trait or condition.
Understanding Your Results
If you have encountered this variant in a genetic report, it is essential to understand that this information is for educational purposes only. This article does not provide medical advice, diagnosis, or treatment recommendations. Genetic variants are complex, and their clinical significance can vary based on an individual's entire genetic background and personal health history. If you are concerned about your genetic results or a family history of polyposis, you should consult with a qualified healthcare professional, such as a genetic counselor or a gastroenterologist. They can help interpret your specific results in the context of your health and provide appropriate guidance regarding any necessary clinical follow-up or screening.
How common is this variant?
The rs377767325 variant is considered rare in the general population, meaning it is not commonly found in large-scale genomic databases of healthy individuals.
Frequently asked questions
What is juvenile polyposis syndrome?
Juvenile polyposis syndrome is a rare genetic condition characterized by the development of multiple benign growths, called polyps, in the gastrointestinal tract. These polyps can sometimes lead to complications such as bleeding or obstruction.
Is rs377767325 the same as other SMAD4 mutations?
No, rs377767325 is a specific, unique variant within the SMAD4 gene. While other mutations in the same gene can also be associated with similar conditions, each variant has its own specific clinical significance.
Should I be worried if I have this variant?
Genetic findings should always be discussed with a healthcare professional. They can provide context based on your personal and family medical history, which is necessary to understand the clinical relevance of any genetic variant.
Where can I find more information about this variant?
You can search for the rsID 'rs377767325' in public databases like ClinVar or the NCBI SNP database. These resources provide curated information from clinical and research studies.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs377767325?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
A well-replicated intronic polymorphism in LPP associated with multi-allergen sensitization, including cat dander, dust mites, and grass pollen.
An intronic regulatory variant in the LPP gene strongly associated with serum allergen-specific IgE levels and allergic rhinitis susceptibility.
This intronic variant in the CASP8 gene is linked to prostate cancer risk assessment models.
This intronic variant is associated with improved risk stratification for clinically significant prostate cancer.
An intronic variant in the ITGA6 gene identified as a marker for prostate cancer risk stratification.
This variant is significantly associated with increased risk of mortality in coronary artery disease patients.